Scarborough Advisors’s Columbia Research Enhanced Core ETF RECS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,202,547
Closed -$52M – 106
2026
Q2
$52M Buy
1,202,547
+664,364
+123% +$28.2M 5.97% 3
2026
Q1
$21M Buy
538,183
+2,243
+0.4% +$91K 2.3% 13
2025
Q4
$21.9M Buy
535,940
+8,369
+2% +$341K 3.7% 9
2025
Q3
$21.3M Sell
527,571
-40,380
-7% -$1.56M 3.76% 9
2025
Q2
$20.9M Buy
567,951
+132,201
+30% +$4.48M 4.14% 8
2025
Q1
$14.5M Buy
435,750
+13,303
+3% +$463K 2.06% 12
2024
Q4
$14.6M Buy
+422,447
New +$14.8M 2.07% 14

Other funds holding RECS

Scarborough Advisors's RECS Position: Q3 2026 in Review

Scarborough Advisors sold out of Columbia Research Enhanced Core ETF (RECS) in Q3 2026, closing a stake of 1,202,547 shares — an estimated $52M sold.

Scarborough Advisors first reported a position in RECS in Q4 2024 and held it in 7 quarters. The position peaked at $52M in Q2 2026. 54 funds tracked by Wall St. Rank hold RECS as of Q3 2026.

  • Scarborough Advisors reported no remaining Columbia Research Enhanced Core ETF position as of Q3 2026 after selling out during the quarter.
  • Scarborough Advisors sold 1,202,547 Columbia Research Enhanced Core ETF shares in Q3 2026, an estimated $52M.
  • Scarborough Advisors first reported a position in Columbia Research Enhanced Core ETF in Q4 2024 and held it in 7 quarters.
  • Scarborough Advisors's Columbia Research Enhanced Core ETF position peaked at $52M in Q2 2026.
  • 54 funds tracked by Wall St. Rank held Columbia Research Enhanced Core ETF as of Q3 2026.

Based on Scarborough Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.